SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a foundational meme reset for the current market cycle. The dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and rallying fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is trending as forecasts for a significant cold snap impacting the East Coast and Midwest in late January and early February are driving expectations for surging natural gas demand. The community is actively discussing a potential short squeeze, citing extreme bearish positioning and a dramatic shift in recent weather models. This renewed short-term bullish sentiment also intertwines with ongoing conversations about growing long-term demand from AI data centers.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

News of CME Group planning Cardano futures is driving significant conversation around $ADA, signaling potential institutional interest. However, community sentiment is sharply divided, with many predicting an imminent "parabolic" rally and "moonshot" from perceived oversold levels. This bullish conviction contrasts with a vocal segment labeling ADA a "scam" and forecasting further declines, often citing broader market anxieties and past performance.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending as recent Phase 3 open-label data indicates an 80% recurrence reduction for its breast cancer vaccine, significantly de-risking the asset. Community discussion highlights a tightly held "micro-float" and persistent open-market share accumulation by the CEO, fueling aggressive short-squeeze narratives amidst high borrowing costs for short sellers. With key biotech conferences approaching, many anticipate potential strategic partnership or acquisition news, further elevating expectations for this oncology company.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending due to persistent analyst downgrades and intense negative sentiment from a community frustrated by its valuation disconnect from market highs. Despite ongoing calls to replace management, many investors are keenly discussing the stock's "deep value" and recent AI-focused partnerships, creating a fierce debate about a potential rebound leading up to its anticipated earnings report.

iShares Ethereum Trust (The) - Undivided Beneficial Interest

iShares Ethereum Trust ETF

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF ($ULTY) is a focal point of discussion following a reverse stock split and a re-evaluated strategy by its management, aiming for greater net asset value (NAV) stability and improved total returns. Community sentiment is sharply divided, with some investors hopeful that increased diversification and capital inflows signal a turnaround, while many others remain critical, pointing to ongoing NAV erosion and inconsistent dividend payouts as evidence of an unsustainable model.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amidst renewed speculation that Sanofi is preparing a heightened takeover bid, following the rejection of its initial $16-per-share offer. The investing community is actively discussing the credibility of these reports, with many interpreting the board's prior refusal as strong confidence in the company's late-stage AXPAXLI drug and pipeline. Conversations are focused on the potential for a significantly increased acquisition price as crucial SOL-1 clinical data approaches.

Global X Funds - Global X Lithium & Battery Tech ETF

Global X Lithium & Battery Tech ETF

Global X Lithium & Battery Tech ETF is trending as lithium prices rebound significantly, fueled by tightening supply dynamics and accelerating demand across the EV and battery technology sectors. The community is actively discussing increased government initiatives to bolster domestic lithium production, emphasizing its crucial role as a strategic resource. This renewed bullish sentiment, following a period of market oversupply, is driving considerable interest in LIT's recent strong performance.

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.

Brainsway Ltd - ADR

Brainsway Ltd.

BrainsWay is trending due to recent FDA clearances for its accelerated Deep TMS protocol, significantly reducing treatment time for major depressive disorder, and expanded insurance coverage, notably for adolescents. The community views these advancements, alongside positive financial performance and analyst upgrades, as validating the company's leadership in non-invasive brain stimulation and enhancing its market opportunity to address critical mental health needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


12Betink

12Bet ink